Athira Pharma, Inc. (ATHA)
4.08
+0.07
(+1.75%)
USD |
NASDAQ |
Dec 10, 15:24
Athira Pharma EPS Diluted (Quarterly): -1.676 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| CEL-SCI Corp. | -1.365 |
| AIM ImmunoTech, Inc. | -1.569 |
| IGC Pharma, Inc. | -0.0201 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Protalix Biotherapeutics, Inc. | 0.0291 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -6.611M |
| Total Expenses (Quarterly) | 6.611M |
| Enterprise Value | -8.499M |
| Earnings Yield | -185.1% |
| Normalized Earnings Yield | -185.05 |